Importer of Controlled Substances Application: Aphena Pharma Solutions MD, LLC, 11439 [2025-03636]
Download as PDF
<![CDATA[
Federal Register / Vol. 90, No. 43 / Thursday, March 6, 2025 / Notices
following basic class(es) of controlled
substance(s):
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1504]
Controlled substance
Importer of Controlled Substances
Application: Aphena Pharma Solutions
MD, LLC
Methamphetamine .....
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Aphena Pharma Solutions
MD, LLC has applied to be registered as
an importer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 7, 2025. Such persons
may also file a written request for a
hearing on the application on or before
April 7, 2025.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the Web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on November 21, 2024,
Aphena Pharma Solutions MD, LLC,
7978 Industrial Park Road, Easton,
Maryland 21601–8600, applied to be
registered as an importer of the
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:42 Mar 05, 2025
Jkt 265001
Drug
code
1105
Schedule
II
11439
Washington, DC 20210, telephone: (202)
693–7638.
Signed at Washington, DC.
Troy W. Finnegan,
Assistant Secretary for Administration and
Management.
[FR Doc. 2025–03621 Filed 3–5–25; 8:45 am]
The company plans to import the
above listed controlled substance for
internal use in the manufacturing of an
FDA-approved exempt OTC drug
product. No other activity for this drug
code is authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–03636 Filed 3–5–25; 8:45 am]
BILLING CODE P
DEPARTMENT OF LABOR
Office of the Secretary
Senior Executive Service; Members of
the Performance Review Board
Title 5 U.S.C. 4314(c)(4) provides that
Notice of the Appointment of an
individual to serve as a member of the
Performance Review Board of the Senior
Executive Service shall be published in
the Federal Register.
The Department of Labor hereby
provides notice that the membership of
its Performance Review Board (PRB),
previously published in the Federal
Register on October 16, 2023, is no
longer in effect.
In accordance with the Executive
Memorandum Restoring Accountability
for Career Senior Executives, the PRB
has been dissolved, and all prior
members have been removed. At this
time, there are no new appointments to
the PRB. In compliance with 5 CFR
430.311(a)(4), the agency will publish a
subsequent notice in the Federal
Register when a new PRB is established
and members are appointed.
This action is being taken to ensure
that the public has notice of the current
status of the PRB for the Department of
Labor.
FOR FURTHER INFORMATION CONTACT:
Tania Burkley, Chief, Division of
Executive Resources, Room N2453, U.S.
Department of Labor, Frances Perkins
Building, 200 Constitution Ave. NW,
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
BILLING CODE 4510–04–P
DEPARTMENT OF LABOR
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request;
Acrylonitrile Standard
Notice of availability; request
for comments.
ACTION:
The Department of Labor
(DOL) is submitting this Occupational
Safety & Health Administration (OSHA)sponsored information collection
request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are
invited.
DATES: The OMB will consider all
written comments that the agency
receives on or before April 7, 2025.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Nicole Bouchet by telephone at 202–
693–0213, or by email at DOL_PRA_
PUBLIC@dol.gov.
SUPPLEMENTARY INFORMATION: The
standard requires employers to monitor
employee exposure to acrylonitrile
(AN), to provide medical surveillance,
to train workers about the hazards of
AN, and to establish and maintain
accurate records of worker exposure to
AN. These records are used by
employers, workers, physicians, and the
Government to ensure that workers are
not harmed by exposure to AN. For
additional substantive information
about this ICR, see the related notice
published in the Federal Register on
October 8, 2025 (89 FR 81577).
Comments are invited on: (1) whether
the collection of information is
necessary for the proper performance of
the functions of the Department,
including whether the information will
have practical utility; (2) the accuracy of
SUMMARY:
E:\FR\FM\06MRN1.SGM
06MRN1
]]>Agencies
[Federal Register Volume 90, Number 43 (Thursday, March 6, 2025)]
[Notices]
[Page 11439]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-03636]
[[Page 11439]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1504]
Importer of Controlled Substances Application: Aphena Pharma
Solutions MD, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Aphena Pharma Solutions MD, LLC has applied to be registered
as an importer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
April 7, 2025. Such persons may also file a written request for a
hearing on the application on or before April 7, 2025.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the Web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on November 21, 2024, Aphena Pharma Solutions MD, LLC,
7978 Industrial Park Road, Easton, Maryland 21601-8600, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Methamphetamine....................... 1105 II
------------------------------------------------------------------------
The company plans to import the above listed controlled substance
for internal use in the manufacturing of an FDA-approved exempt OTC
drug product. No other activity for this drug code is authorized for
this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-03636 Filed 3-5-25; 8:45 am]
BILLING CODE P
